LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 3.21 | 770.25 | 868 | 904 | 0.9595 | 0.6736 | MN20160304_L02 | D15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 5.44 | 770.25 | 998 | 1012 | 0.9854 | 0.9271 | MN20160304_L02 | C08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 5.44 | 770.25 | 995 | 1012 | 0.9825 | 0.9124 | MN20160304_L02 | D15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 7.66 | 770.25 | 1078 | 1090 | 0.9890 | 0.9563 | MN20160304_L02 | C08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 7.66 | 770.25 | 1056 | 1090 | 0.9688 | 0.8774 | MN20160304_L02 | D15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 10.06 | 770.25 | 1199 | 1218 | 0.9840 | 0.9518 | MN20160304_L02 | C08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 10.06 | 770.25 | 1175 | 1218 | 0.9643 | 0.8931 | MN20160304_L02 | D15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 12.28 | 770.25 | 1350 | 1358 | 0.9940 | 0.9854 | MN20160304_L02 | C08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 12.28 | 770.25 | 1301 | 1358 | 0.9579 | 0.8977 | MN20160304_L02 | D15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 14.50 | 770.25 | 1498 | 1497 | 1.0005 | 1.0010 | MN20160304_L02 | C08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 14.50 | 770.25 | 1468 | 1497 | 0.9805 | 0.9593 | MN20160304_L02 | D15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 16.73 | 770.25 | 1659 | 1664 | 0.9967 | 0.9941 | MN20160304_L02 | C08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 16.73 | 770.25 | 1613 | 1664 | 0.9691 | 0.9443 | MN20160304_L02 | D15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 18.95 | 770.25 | 1809 | 1832 | 0.9872 | 0.9795 | MN20160304_L02 | C08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 18.95 | 770.25 | 1754 | 1832 | 0.9572 | 0.9312 | MN20160304_L02 | D15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 21.17 | 770.25 | 1945 | 2008 | 0.9684 | 0.9542 | MN20160304_L02 | C08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 21.17 | 770.25 | 1905 | 2008 | 0.9485 | 0.9250 | MN20160304_L02 | D15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 23.39 | 770.25 | 2158 | 2244 | 0.9615 | 0.9497 | MN20160304_L02 | C08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 23.39 | 770.25 | 2127 | 2244 | 0.9477 | 0.9315 | MN20160304_L02 | D15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 25.62 | 770.25 | 2383 | 2514 | 0.9476 | 0.9379 | MN20160304_L02 | C08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 25.62 | 770.25 | 2401 | 2514 | 0.9547 | 0.9464 | MN20160304_L02 | D15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 27.84 | 770.25 | 2770 | 2833 | 0.9775 | 0.9759 | MN20160304_L02 | C08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 27.84 | 770.25 | 2760 | 2833 | 0.9739 | 0.9721 | MN20160304_L02 | D15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 30.06 | 770.25 | 3063 | 3106 | 0.9861 | 0.9862 | MN20160304_L02 | C08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 30.06 | 770.25 | 3040 | 3106 | 0.9787 | 0.9787 | MN20160304_L02 | D15 |